In vitro hypoxic cytotoxicity of nitroimidazoles: Uptake and cell cycle phase specificity

This publication has 10 references indexed in Scilit:

• Low concentrations of misonidazole counteract effects of extreme hypoxia on cells in S
  British Journal of Cancer, 1981
• In vivo response of KHT sarcomas to combination chemotherapy with radiosensitizers and BCNU
  British Journal of Cancer, 1981
• Resistance to adriamycin in multicellular spheroids
  International Journal of Radiation Oncology*Biology*Physics, 1979
• Initial United States clinical and pharmacologic evaluation of misonidazole (Ro-07-0582), an hypoxic cell radiosensitizer
  International Journal of Radiation Oncology*Biology*Physics, 1979
• Estimation of the hypoxic cell-sensitiser misonidazole and its O-demethylated metabolite in biological materials by reversed-phase high-performance liquid chromatography
  Journal of Chromatography B: Biomedical Sciences and Applications, 1978
• Amino acid-conferred protection against melphalan—Characterization of melphalan transport and correlation of uptake with cytotoxicity in cultured L1210 murine leukemia cells
  Biochemical Pharmacology, 1978
• Ro-07-0582 as a radiosensitizer and cytotoxic agent
  International Journal of Radiation Oncology*Biology*Physics, 1977
• Clinical testing of the radiosensitizer Ro 07-0582: Experience with multiple doses
  British Journal of Cancer, 1977
• Clinical Phase I Study of the Hypoxic Cell Radiosensitizer RO-07-0582, A 2-Nitroimidazole Derivative
  Radiology, 1977
• Radiosensitizing and Toxic Effects of the 2-Nitroimidazole Ro-07-0582 in Hypoxic Mammalian Cells
  Radiation Research, 1976